Hint mode is switched on Switch off
For swift navigation between sections

Disc Medicine

PDF download

Choose all Reset all
Download Cancel
Organization name
Disc Medicine Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Disc Medicine, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. Disc Medicine develops therapeutic candidates that aim to address spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology.

Awards

News

25/06/2026 Disc Medicine: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant
26/02/2026 Disc Medicine: Costs Associated With Exit Or Disposal Activities
17/02/2026 Disc Medicine: Regulation Fd Disclosure, Financial Statements And Exhibits
13/02/2026 Disc Medicine: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
16/01/2026 Disc Medicine, Inc. (NASDAQ:IRON) Maintains "Outperform" Rating Amidst Market Volatility
All organization news

Documentation

IFRS/US GAAP reports

2026
II q eng
2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001816736
  • EIN
    85-1613057
Registration is required to get access.